GALECTO, INC. GLTO 深 滬
等待開盤 09-10 09:30:00 美东时间
2.58
-0.510
-16.50%
華盛通- 最 高2.70
- 今 開2.65
- 成交量 35.94万股
- 最 低 2.45
- 昨 收 3.09
- 總市值 341.18万
- 52周最高 13.27
- 市盈率 靜 --
- 換手率 27.18%
- 52周最低 2.01
- 委 比 83.28%
- 總股本 132.24万
- 歷史最高 449.75
- 量 比 0.85
- 振 幅 8.09%
- 歷史最低 2.01
- 每 手 1
- 風險率 2.88%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多12 Health Care Stocks Moving In Tuesday's Intraday Session
Gainers iSpecimen (NASDAQ:ISPC) shares increased by 80.7% to $1.35 during Tues...
今天 01:06
Galecto GAAP EPS of -$2.60
Galecto press release (NASDAQ:GLTO): Q2 GAAP EPS of -$2.60. Cash and cash equivalents as of June 30, 2025, were approximately $10.2 million. More on Galecto Seeking Alpha’s Quant Rating on Galecto Hi...
08-06 05:36
Galecto Q2 EPS $(2.60) Up From $(5.00) YoY
Galecto (NASDAQ:GLTO) reported quarterly losses of $(2.60) per share. This is a 48 percent increase over losses of $(5.00) per share from the same period last year.
08-06 04:55
Galecto Reports Second Quarter 2025 Operating and Financial Results
On August 5, 2025, Galecto, Inc. announced its Q2 2025 financial results, highlighting cash of $10.2 million and a net loss of $3.4 million. The company emphasized advancing GB3226, a dual ENL-YEATS and FLT3 inhibitor for AML, aiming for an IND filing in Q1 2026. R&D expenses decreased to $1.5 million, while general and administrative costs also fell to $2.0 million. Galecto outlined its pipeline, including GB3226 and GB1211, and stressed the nee...
08-05 20:15
Galecto GAAP EPS of -$1.92
Galecto press release (NASDAQ:GLTO): Q1 GAAP EPS of -$1.92. Cash and cash equivalents as of March 31, 2025 were approximately $11.9 million More on Galecto Seeking Alpha’s Quant Rating on Galecto Hist...
05-09 15:21
Galecto Q1 EPS $(1.92) Up From $(5.05) YoY
Galecto (NASDAQ:GLTO) reported quarterly losses of $(1.92) per share. This is a 61.98 percent increase over losses of $(5.05) per share from the same period last year.
05-09 04:45
Galecto, Inc. Focuses on Oncology and Liver Diseases
Galecto, Inc. ( ($GLTO) ) has released its Q4 earnings. Here is a breakdown of ...
04-04 11:56
Galecto GAAP EPS of -$18.53 misses by $2.62
Galecto press release (NASDAQ:GLTO): FY GAAP EPS of -$18.53 misses by $2.62. Cash and cash equivalents as of December 31, 2024 were approximately $14.2 million. The Company anticipates that its cash a...
03-20 04:52
Galecto FY 2024 GAAP EPS $(18.53) Misses $(15.91) Estimate
Galecto (NASDAQ:GLTO) reported quarterly losses of $(18.53) per share which missed the analyst consensus estimate of $(15.91) by 16.47 percent. This is a 48.64 percent increase over losses of $(36.08) per share from the
03-20 04:48
Galecto, Inc. Announces Strategic Shift and Financial Overview
Galecto, Inc. ( ($GLTO) ) has released its Q3 earnings. Here is a breakdown of ...
2024-11-02 12:13
